Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06966427 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Evaluation of a Dose Guidance System for People With Diabetes Initiating Basal Insulin or Using Insulin Injections

Study acronym: DGS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 11, 2025 (before its estimated May 25, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Rabin Medical Center
29 trials monitored
See 1 trial at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
Type 2 Diabetes
2,231 trials monitored
See 111 trials at risk
Type 1 Diabetes
886 trials monitored
See 40 trials at risk
A prospective, randomized, single blind, two-arms, multicenter study. The study aims to assess the safety of a dosing-guided system (DGS) that provides direct advice on insulin dosing recommendations and diabetes management to individuals with diabetes using insulin or starting basal insulin therapy, guided by their continuous glucose monitoring (CGM). The study population will include up to 45 individuals with diabetes, distributed as follows: 15 with Type 1 diabetes (T1D) and 15 with Type 2 diabetes (T2D), both on MDI therapy and 15 with T2D using or starting to use basal insulin. The study will include a 2- to 4-week run-in period followed by a 6-week intervention period.
Trial Details
NCT Number NCT06966427
Lead Sponsor Rabin Medical Center
Collaborators: DreaMed Diabetes
Conditions
(from sponsor)		 Type 1 Diabetes, Type 2 Diabetes
Related terms Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Enrollment 45 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov